<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03426306</url>
  </required_header>
  <id_info>
    <org_study_id>17-2216.cc</org_study_id>
    <nct_id>NCT03426306</nct_id>
  </id_info>
  <brief_title>A Novel Lung Function Imaging Modality as a Preoperative Evaluation Tool (LIME)</brief_title>
  <official_title>A Novel Lung Function Imaging Modality as a Preoperative Evaluation Tool (LIME)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the correlation between pre-surgical 4DCT-ventilation imaging and post-surgical
      lung function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the correlation between pre-surgical 4-Dimensional Computed
      Tomography-ventilation (4DCT-ventilation) imaging and post-surgical lung function. To
      determine whether 4DCT-ventilation is a better predictor of post-surgical lung function than
      nuclear medicine imaging using pulmonary function tests (PFTs). To determine whether
      4DCT-ventilation is a better predictor of post-surgical lung function than nuclear medicine
      imaging using quality of life (QOL) questionnaires. Evaluate cost-effectiveness of using
      4DCT-ventialtion and VQ scans for pre-surgical assessment. To use longitudinal (pre and
      post-surgical) 4DCT-ventilation imaging to derive novel post-surgical prediction formulas.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 21, 2018</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pre-Surgical Imaging and Post-Surgical Lung Function</measure>
    <time_frame>Baseline visit to follow up visit, up to 9 months.</time_frame>
    <description>Measure the correlation between pre-surgical 4-Dimensional Computed Tomography-ventilation (4DCT) imaging and post surgical lung function using a Percent Predicted Post-Operative Pulmonary Function Test (%PPO PFT).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ability of %PPO PFTs</measure>
    <time_frame>Start of study to end of study, up to 2 years</time_frame>
    <description>Use %PPO PFTs to determine if 4DCT-ventilation is a better predictor of post surgical lung function than nuclear medicine imaging</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QOL)</measure>
    <time_frame>Start of study to end of study, up to 2 years</time_frame>
    <description>Use QOL questionnaires to determine if 4DCT-ventilation is a better predictor of post surgical lung function than nuclear medicine imaging.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost-Effectiveness</measure>
    <time_frame>Start of study to end of study, up to 2 years</time_frame>
    <description>Determine the cost-effectiveness of 4DCT-ventialtion and VQ scans for pre-surgical assessment using Receiver Operator Characteristic (ROC) analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Longitudinal Imaging Changes</measure>
    <time_frame>Start of study to end of study, up to 2 years</time_frame>
    <description>Derive novel post-surgical prediction formulas using longitudinal 4DCT-ventilation imaging</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>4DCT-ventilation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patient will undergo 4DCT imaging. The 4DCT imaging data along with image processing techniques will be used to generate a 4DCT-ventilation map. All surgical decisions will be based on the current standard of care imaging (VQ scans) and not on the 4DCT imaging results.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>4DCT-Ventilation</intervention_name>
    <description>4DCT-ventilation is an imaging modality that provides superior image quality, reduced cost, and a faster imaging procedure compared to nuclear medicine VQ scans.</description>
    <arm_group_label>4DCT-ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Provision to sign and date the consent form.

          2. Stated willingness to comply with all required (non-optional) study procedures and be
             available for the duration of the study.

          3. Be a male or female aged 18 to 100.

          4. Patient with lung cancer (presumed or biopsy proven) currently undergoing or having
             undergone evaluation for resection.

          5. Lung function assessment required for pre-surgical evaluation at the discretion of the
             cardiothoracic surgeon.

          6. Life expectancy greater than 3 months.

        Exclusion Criteria:

        1. Patients getting a planned wedge resection as the only thoracic resectional procedure.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yevgeniy Vinogradskiy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robyn Swing</last_name>
    <phone>720-848-0607</phone>
    <email>Robyn.swing@ucdenver.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Colorado Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robyn Swing</last_name>
      <phone>720-848-0607</phone>
      <email>robyn.swing@ucdenver.edu</email>
    </contact>
    <investigator>
      <last_name>Yevgeniy Vinogradskiy, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UCHealth Memorial Hospital</name>
      <address>
        <city>Colorado Springs</city>
        <state>Colorado</state>
        <zip>80920</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angie Valdez</last_name>
      <phone>719-365-2406</phone>
      <email>angie.valdez@uchealth.org</email>
    </contact>
    <investigator>
      <last_name>Matthew Blum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>February 1, 2018</study_first_submitted>
  <study_first_submitted_qc>February 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 8, 2018</study_first_posted>
  <last_update_submitted>March 5, 2020</last_update_submitted>
  <last_update_submitted_qc>March 5, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>4-Dimensional Computed Tomography</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

